Global Internal Nasal Dilators Market - 2022-2029

Market Overview

The global internal nasal dilators market size was valued at US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of XX% during the forecast period (2022-2029).

Internal nasal dilators are devices inserted into the nostrils to help expand the nasal passages and improve breathing. They can help alleviate nasal congestion and improve airflow in people with nasal obstruction caused by conditions such as nasal polyps, deviated septum, or allergies. Several types of internal nasal dilators are available, including spring-loaded devices, adhesive strips, and silicone plugs. These devices can be used with other treatment options, such as nasal sprays or oral medications, to help manage symptoms of nasal obstruction.

Market Dynamics

The global internal nasal dilators market growth is driven by technological advancements, the rising prevalence of nasal disorders, increasing awareness of nasal disorders, the growing number of nasal surgery, changing lifestyles and increasing air pollution, increased healthcare expenditure, and a shift in focus towards home-based treatments.

An increasing prevalence of Snoring and obstructive sleep apnea (OSA) diseases drives the market growth

Snoring and obstructive sleep apnea (OSA) can induce excessive daytime sleepiness, increased risk of car accidents, and several cardiovascular and neurovascular medical complications. As per the article published in the American Thoracic Society in 2020, Obstructive sleep apnea (OSA) affects an estimated 936 million adults 30-69 years old worldwide, with approximately 425 million adults experiencing moderate to severe disease. In the U.S., conservative estimates suggest that 6% of women and 13% of men have clinically significant OSA, defined as an apnea-hypopnea index (AHI) of 15 events or greater. OSA has major neurocognitive and cardiovascular sequelae, but optimal treatment can be challenging.

Nasal dilators have also been proposed in patients with obstructive sleep apnea syndrome (OSAS). OSAS is a prevalent sleep disorder with significant public health outcomes. Continuous positive airway pressure (CPAP) is considered the primary medical treatment for patients with moderate to severe OSAS, as evidenced by several randomized controlled trials.

High cost of internal nasal dilators will hamper the growth of the market

However, the high cost of some internal nasal dilators can be a barrier for some individuals and may limit their adoption. Prices for internal nasal dilators can vary widely, depending on the type of device and the brand. Some internal nasal dilators can be inexpensive, while others can be quite costly. For example, a pack of adhesive nasal strips may cost less than $10, while a prescription-only, spring-loaded nasal dilator can cost several hundred dollars. These high costs may make it difficult for some individuals to afford the devices, especially those without insurance coverage or with high deductibles. Additionally, to the high cost, it is important to mention the lack of reimbursement by the insurance company as a factor that will impact on internal nasal dilator market; this can be challenging for both manufacturers and consumers. This can limit their use, as individuals may opt for cheaper treatment options covered by their insurance.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a significant impact on the market for internal nasal dilators. These devices are used to treat nasal congestion and other breathing-related issues, and demand for them has increased due to the pandemic. One reason is that COVID-19 can cause respiratory symptoms such as nasal congestion, which has increased demand for products that can help alleviate these symptoms. Additionally, many people have been experiencing anxiety and stress related to the pandemic, which can cause nasal congestion. Moreover, many countries have seen an increase in remote working and telemedicine, leading to more people seeking treatment for nasal congestion and other breathing issues from their homes. This increased demand for at-home treatments has also helped boost demand for internal nasal dilators.

Segment Analysis

The sleep apnea segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The sleep apnea segment accounts for the highest market share. The nasal valve area has a minimal cross-sectional area of the upper airways. Obstructive sleep apnea syndrome (OSAS) is a common disorder. It has been reported that nasal obstruction may be associated with OSAS.

McKeon Products offers AIRMAX Nasal Dilator for Better Sleep - Two Size Trial Pack - (Small and Medium - Clear), a simple solution for individuals who have sleeping and breathing difficulties; designed to be comfortably placed inside the nasal passages - it is patented, aerodynamic winged design is clinically proven to help improve airflow by expanding the nasal passages, Clinically proven to help reduce snoring and mild sleep apnea. To relieve nasal congestion, An FDA cleared medical device made of hypoallergenic, medical grade material that is soft, flexible and comfortable; more effective than Breathe Right Nasal Strips, Available in medium (fits most) and small, and includes a carrying case and A patented design.

Geographical Analysis

North America region holds the largest market share of the global Internal Nasal Dilators market

North America dominates the market for internal nasal dilators and is expected to show a similar trend over the forecast period. Technological advancements, the rising prevalence of nasal disorders, and product launches by market players in the North American region drive the market.

Sinusitis is one of the most common chronic conditions in the United States, affecting fifty million Americans, 20% of the nation's population. Sinusitis is a chronic (ongoing) disease that includes the symptoms of nasal obstruction (difficulty breathing through the nose), nasal drainage, decreased sense of smell, facial pressure, and frequent sinus infections.

As per the UCI Health, Nose and sinus disorders afflict millions of people, causing pain, fatigue, headache, breathing difficulties and loss of smell, among other symptoms. Sinusitis alone affects about 37 million people at least once yearly, making it one of the most common illnesses in the United States.

Competitive Landscape

The internal nasal dilators market is a moderately competitive presence of local and global companies. Some of the key players which are contributing to the growth of the market are Rhinomed Limited, Splintek Inc, Nasanita, SHREYAAS HEALTH CARE PVT LTD, Scandinavian Formulas, Airware Labs, Tomed GmbH, Nasilator, HealthRight Products, LLC, SIBEL, S.A.U., and GlaxoSmithKline plc, among others. The major players are adopting several growth strategies, such as Type launches, acquisitions, and collaborations, contributing to the growth of the internal nasal dilators market globally.

Rhinomed Limited

Overview:

Rhinomed is an airway technology organization that seeks to improve how you breathe radically, sleep, maintain your health and take medication. Rhinomed's patented nasal technology leverages the physiology of the nose to optimize our breathing which is essential to restful sleep and maintaining good health.

Product Portfolio:

MUTE TRIAL PACK: A nasal breathing device called Mute softly opens your airways to boost airflow via your nose as you sleep.

The global internal nasal dilators market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.